Conferences & Events

IASLC-FDA Lung Cancer Neoadjuvant Meeting 2018 (#LCN18)

This initial meeting between the FDA, IASLC, industry and investigators is designed to facilitate discussions regarding the standardization of endpoints in neoadjuvant lung cancer trials and to discuss how said endpoints can be validated by comparing novel endpoints to established time to event endpoints.

IASLC 18th Lung Cancer Targeted Therapies Meeting (#LCTT18)

Targeted Therapies Icon

This IASLC-sponsored meeting is designed to provide information about ongoing clinical trials of the newest therapies for lung cancer.

Fifth AACR-IASLC International Joint Conference on Lung Cancer Translational Science: From the Bench to the Clinic

Under the leadership of Margaret Foti, PhD, MD (h.c.), CEO of the American Association for Cancer Research (AACR), and Fred R. Hirsch, MD, PhD, CEO of the International Association for the Study of Lung Cancer (IASLC), we are thrilled to join in our fifth biennial conference on lung cancer research and treatment. The translational science featured at this conference will include basic research foundation at the bench to patient care in the clinic.

Best of WCLC 2017 - San Francisco

A one day CME conference discussing the latest advances in lung cancer and other thoracic malignancies that were shared at the IASLC 18th World Conference on Lung Cancer on Oct. 15-18, 2017, in Yokohama, Japan.